BNP/NT-proBNP Cutoffs Stratified for PH (Calculator)

Clinical calculation support · Verify results before clinical use

Enter biomarker result

Classify a BNP or NT-proBNP value using one of the pulmonary arterial hypertension risk frameworks.

CLINICAL
RISK TOOL
Use the unit reported by the laboratory; this calculator expects ng/L.
Enter a non-negative numeric result.
The three-strata model is used for comprehensive assessment at diagnosis; the four-strata approach is commonly used for follow-up.
Reset

About BNP/NT-proBNP thresholds

Natriuretic peptide concentrations provide information about myocardial wall stress and prognosis in pulmonary arterial hypertension (PAH). Thresholds are interpreted as one part of a multiparametric assessment, rather than as a standalone diagnostic test or complete patient risk classification.

ESC/ERS 2022 — three strata

CategoryBNPNT-proBNP
Low<50 ng/L<300 ng/L
Intermediate50–800 ng/L300–1100 ng/L
High>800 ng/L>1100 ng/L

COMPERA 2.0 — four strata

CategoryBNPNT-proBNP
Low<50 ng/L<300 ng/L
Intermediate-low50–199 ng/L300–649 ng/L
Intermediate-high200–800 ng/L650–1100 ng/L
High>800 ng/L>1100 ng/L

At exact boundary values, the calculator assigns 50 BNP to intermediate, 200 BNP to intermediate-high, 800 BNP to intermediate-high, and values above 800 to high; for NT-proBNP it assigns 300 to intermediate, 650 to intermediate-high, 1100 to intermediate/intermediate-high, and values above 1100 to high. For continuous laboratory values between integer cutoffs, category assignment follows the numerical thresholds.

References

Humbert M, Kovacs G, Hoeper MM, et al.2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Respiratory Journal. 2023;61:2200879. DOI: 10.1183/13993003.00879-2022.
View guideline (DOI)
Hoeper MM, Pausch C, Olsson KM, et al.COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension. European Respiratory Journal. 2022;60:2102311. The thresholds shown here are also reproduced in the 2022 ESC/ERS guideline Table 18.

Important limitations

  • These thresholds are intended for risk assessment in PAH, not as a stand-alone screening or diagnostic test for all forms of pulmonary hypertension.
  • Natriuretic peptide levels may be affected by other cardiac disease, age, and renal function.
  • The COMPERA four-strata tool ordinarily integrates WHO functional class and 6-minute walk distance with the biomarker; this calculator classifies the biomarker component only.
Clinical disclaimer: This tool is for clinical decision support and education. It does not replace comprehensive assessment, specialist judgement, or local protocols. Confirm the assay, units, patient context, and applicable guideline before acting on a result.